Nevro (NVRO) News Today → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free NVRO Stock Alerts $10.56 +0.68 (+6.88%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 6:29 PM | markets.businessinsider.comBank of America Securities Keeps Their Sell Rating on Nevro Corp (NVRO)May 13 at 1:49 AM | markets.businessinsider.comTruist Financial Remains a Hold on Nevro Corp (NVRO)May 11, 2024 | americanbankingnews.comCanaccord Genuity Group Trims Nevro (NYSE:NVRO) Target Price to $11.00May 11, 2024 | americanbankingnews.comWilliam Blair Comments on Nevro Corp.'s Q2 2024 Earnings (NYSE:NVRO)May 10, 2024 | markets.businessinsider.comNevro Corp: Cautious Outlook Amidst Restrained Growth and Strategic EffortsMay 10, 2024 | finance.yahoo.comEarnings Release: Here's Why Analysts Cut Their Nevro Corp. (NYSE:NVRO) Price Target To US$15.30May 10, 2024 | marketbeat.comQ2 2024 Earnings Estimate for Nevro Corp. (NYSE:NVRO) Issued By William BlairNevro Corp. (NYSE:NVRO - Free Report) - Equities researchers at William Blair lowered their Q2 2024 earnings estimates for Nevro in a research note issued to investors on Tuesday, May 7th. William Blair analyst B. Vazquez now anticipates that the medical equipment provider will earn ($0.78) per sMay 10, 2024 | americanbankingnews.comWells Fargo & Company Lowers Nevro (NYSE:NVRO) Price Target to $13.00May 10, 2024 | americanbankingnews.comNevro Corp. (NYSE:NVRO) Forecasted to Earn Q1 2025 Earnings of ($0.92) Per ShareMay 10, 2024 | americanbankingnews.comPiper Sandler Trims Nevro (NYSE:NVRO) Target Price to $12.00May 9, 2024 | prnewswire.comNevro to Present at BofA Securities 2024 Healthcare ConferenceMay 9, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Nevro Corp.'s Q1 2025 Earnings (NYSE:NVRO)Nevro Corp. (NYSE:NVRO - Free Report) - William Blair issued their Q1 2025 earnings estimates for Nevro in a note issued to investors on Tuesday, May 7th. William Blair analyst B. Vazquez forecasts that the medical equipment provider will earn ($0.92) per share for the quarter. The consensus estiMay 8, 2024 | markets.businessinsider.comAssessing Nevro: Insights From 9 Financial AnalystsMay 8, 2024 | markets.businessinsider.comHold Rating on Nevro Corp Amidst Strong Q1 Performance and Conservative OutlookMay 8, 2024 | finance.yahoo.comNevro Corp. (NYSE:NVRO) Q1 2024 Earnings Call TranscriptMay 8, 2024 | marketbeat.comNevro (NYSE:NVRO) Price Target Lowered to $11.00 at Canaccord Genuity GroupCanaccord Genuity Group dropped their target price on shares of Nevro from $17.00 to $11.00 and set a "hold" rating on the stock in a research note on Wednesday.May 8, 2024 | marketbeat.comNevro (NYSE:NVRO) Issues Quarterly Earnings ResultsNevro (NYSE:NVRO - Get Free Report) issued its quarterly earnings data on Tuesday. The medical equipment provider reported ($0.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.02) by $0.32. The firm had revenue of $101.90 million for the quarter, compared to analyst estimates of $97.90 million. Nevro had a negative net margin of 21.69% and a negative return on equity of 30.22%. Nevro's revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.98) EPS.May 8, 2024 | finance.yahoo.comNevro Corp (NVRO) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of Financial ...May 7, 2024 | prnewswire.comNevro Reports First-Quarter 2024 Financial ResultsMay 7, 2024 | markets.businessinsider.comNevro earnings preview: what Wall Street is expectingMay 7, 2024 | americanbankingnews.comNevro Corp. (NYSE:NVRO) Receives Average Rating of "Hold" from AnalystsApril 30, 2024 | marketbeat.comNevro (NVRO) Scheduled to Post Earnings on TuesdayNevro (NYSE:NVRO) will be releasing earnings after the market closes on Tuesday, May 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=585524)April 25, 2024 | marketbeat.comFederated Hermes Inc. Has $9.28 Million Position in Nevro Corp. (NYSE:NVRO)Federated Hermes Inc. grew its holdings in Nevro Corp. (NYSE:NVRO - Free Report) by 380.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 431,153 shares of the medical equipment provider's stock after purchasingApril 17, 2024 | finance.yahoo.comNevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024April 17, 2024 | prnewswire.comNevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024April 15, 2024 | marketbeat.comNevro (NYSE:NVRO) Price Target Lowered to $16.00 at Royal Bank of CanadaRoyal Bank of Canada dropped their target price on Nevro from $18.00 to $16.00 and set a "sector perform" rating for the company in a report on Monday.April 12, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Given Average Rating of "Hold" by AnalystsNevro Corp. (NYSE:NVRO - Get Free Report) has been given a consensus recommendation of "Hold" by the thirteen research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and one has issApril 11, 2024 | marketbeat.comMizuho Cuts Nevro (NYSE:NVRO) Price Target to $16.00Mizuho lowered their price target on Nevro from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Thursday.April 9, 2024 | marketbeat.comNevro (NYSE:NVRO) Trading Up 5.5%Nevro (NYSE:NVRO) Trading 5.5% HigherApril 5, 2024 | marketbeat.comAssenagon Asset Management S.A. Lowers Stock Holdings in Nevro Corp. (NYSE:NVRO)Assenagon Asset Management S.A. reduced its stake in Nevro Corp. (NYSE:NVRO - Free Report) by 81.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 79,056 shares of the medical equipment provider's stock after selling 348,686 sApril 3, 2024 | benzinga.comWhere Nevro Stands With AnalystsApril 3, 2024 | marketbeat.comCitigroup Trims Nevro (NYSE:NVRO) Target Price to $16.00Citigroup reduced their target price on shares of Nevro from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday.April 1, 2024 | marketbeat.comNevro (NYSE:NVRO) Stock Price Down 4.8%Nevro (NYSE:NVRO) Trading Down 4.8%March 25, 2024 | finanznachrichten.deEnviroGold Global Limited: NVRO announces Management Changes and provides an update on its Proprietary Leaching Technology CommercializationMarch 18, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Given Consensus Rating of "Hold" by AnalystsNevro Corp. (NYSE:NVRO - Get Free Report) has earned a consensus recommendation of "Hold" from the thirteen ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and one has issuedMarch 17, 2024 | marketbeat.comWalleye Capital LLC Raises Stake in Nevro Corp. (NYSE:NVRO)Walleye Capital LLC lifted its position in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 301.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 118,764 shares of the medical equipmMarch 11, 2024 | finance.yahoo.comNVRO Mar 2024 20.000 putMarch 5, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Shares Sold by Fmr LLCFmr LLC trimmed its holdings in Nevro Corp. (NYSE:NVRO - Free Report) by 76.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,084,625 shares of the medical equipment provider's stock after selling 3,455,207March 1, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Shares Purchased by Palo Alto Investors LPPalo Alto Investors LP grew its stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 107.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 386,832 shares of the medical equiFebruary 28, 2024 | prnewswire.comNevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewFebruary 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Nevro Corp (NVRO), Karuna Therapeutics (KRTX) and Gilead Sciences (GILD)February 26, 2024 | markets.businessinsider.comNevro Corp: Hold Rating Affirmed Amidst Mixed Performance and Market UncertaintyFebruary 23, 2024 | marketbeat.comNevro (NYSE:NVRO) Stock Price Down 7% After Analyst DowngradeNevro (NYSE:NVRO) Shares Down 7% on Analyst DowngradeFebruary 23, 2024 | marketbeat.comEquities Analysts Offer Predictions for Nevro Corp.'s FY2025 Earnings (NYSE:NVRO)Nevro Corp. (NYSE:NVRO - Free Report) - Research analysts at William Blair issued their FY2025 earnings per share estimates for Nevro in a research report issued on Thursday, February 22nd. William Blair analyst B. Vazquez expects that the medical equipment provider will post earnings of ($2.58)February 23, 2024 | realmoney.thestreet.comNevro just downgraded at Oppenheimer, here's whyFebruary 22, 2024 | marketbeat.comNevro (NYSE:NVRO) Lowered to Sell at StockNews.comStockNews.com cut Nevro from a "hold" rating to a "sell" rating in a report on Thursday.February 22, 2024 | finanznachrichten.deNevro Corp.: Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsFebruary 22, 2024 | fool.comWhy Nevro Stock Lagged the Market on ThursdayFebruary 22, 2024 | markets.businessinsider.comHold Rating on Nevro Corp Amid Modest Growth and Cautious 2024 OutlookFebruary 22, 2024 | markets.businessinsider.comAnalyst Scoreboard: 4 Ratings For Nevro Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address This is the best new way to score with AI (Ad)If you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open. Click now for the best way into the newest AI projects NVRO Media Mentions By Week NVRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVRO News Sentiment▼0.210.55▲Average Medical News Sentiment NVRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVRO Articles This Week▼183▲NVRO Articles Average Week Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cerus News Today Pulmonx News Today Beauty Health News Today Anika Therapeutics News Today Tactile Systems Technology News Today OraSure Technologies News Today Fractyl Health News Today Treace Medical Concepts News Today Pulse Biosciences News Today TriSalus Life Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVRO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
